This case highlights the risk of very late stent thrombosis in bare-metal stents even 9 years post-implantation, emphasizing the importance of long-term antiplatelet therapy adherence.
Alerts to very late BMS thrombosis risk with aspirin nonadherence; single case leaves open need for lifelong therapy.
Very late bare-metal stent thrombosis occurring beyond one year after stenting is uncommon. We report a case of bare-metal stent thrombosis presenting as acute myocardial infarction. The patient's stent was implanted 9 years ago, however, he was not adherent to his antiplatelet therapy (aspirin). This case highlights the importance of antiplatelet therapy in patients with stents even many years after implantation.
No takes yet. Share an insight, caveat, or question.
Adel Almasswary (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: